SUMMARY Six screening methods for the successful detection of significant bacteriuria-electrical impedance (Malthus), automated acridine-orange staining (Autotrak), particle counting (Ramus), bioluminescence, nitrite and leucocyte test strip (BM Nephur), and microscopy-were evaluated. All had excellent predictive values for a negative result (97%-100%) but were less accurate in predicting a positive result (31%-83%). All methods had high sensitivities (83%-100%) but lower levels of specificity (68%-79%). Bioluminescence was the method with the highest specificity (79%) and the lowest rate of false positive results (15%).
Hospital diagnostic laboratories investigate many thousands of urine specimens each year, but only a small proportion (about 25-30%) are infected.' 2 Large amounts of both staff time and culture media are consequently expended on specimens that eventually yield insignificant growth. Conventional methods for diagnosing urinary tract infections entail the quantitative or semiquantitative culture of urine specimens on solid culture medium.34 Results are read after overnight incubation, and a pure growth of a single bacterial species in numbers of > 105 organisms/ ml is accepted as indicative of infection. 5 Many screening methods have been advocated for use in detecting bacteria in urine. These include measurements of bacterial adenosine tri-phosphate by luciferase,67 measurement of heat generated by metabolising organisms,8 changes in electrical impedance,91" automated photometric systems '2 13 which detect growth by changes in light transmission, particle counting,2 14 chemical analysis,'>"7 fluorescence staining using acridine-orange,'I'9 and filter staining techniques.'
We report the results of our investigations in which we evaluated six screening methods for their ability to detect significant bacteriuria. These were the Malthus 128H growth analyser (Malthus Ltd, Stoke on Trent, England), the Autotrak (Roche Ltd, Welwyn Garden City, Hertfordshire), the Ramus 256 (Orbec Ltd, Accepted for publication 3 March 1988 Sanderstead, Surrey), ATP bioluminescence assay using the Amerlite analyser (Amersham International Ltd, England), the Nephur test and leucocyte test strips (Boehringer-Mannheim Ltd, West Germany) and microscopy using microtitration plates. Results were directly compared with those obtained by the semiquantitative culture plate method which was the reference technique used throughout all our evaluations. The Autotrak can screen about 120 specimens every hour with a result-lead time of less than 60 seconds from specimen presentation to printout of results. About I ml of urine is pipetted into each specimen container, which in turn is inserted into a plastic feeding chain. A maximum of 50 specimen containers can be accommodated into the feeding chain, which is automatically fed into the Autotrak from the loading stage.
Material and methods

SEMIQUANTITATIVE
PARTICLE COUNTING The method of particle counting was evaluated by screening 1058 urines with the Orbec Ramus 256 machine. This is an automated electronic particle counter which uses a direct physical method to count and categorise particles. The urine sample is diluted with an electrolyte solution (Orbec U-lyte) and then offered to the particle counting probe. There is a small orifice (30 gm in diameter) in the glass wall of the probe. Two platinum electrodes, internal and external, are mounted on the wall and an electrical field is established between them via the electrolyte solution in the orifice. As a particle of the sample is drawn into the orifice and enters the electrical field, it displaces its own volume of electrolyte causing a change in impedance of the system. These changes are seen as pulses, the number of pulses indicating the number of particles present. The height ofpulse is proportional to the volume of each particle. Thus by passing a known volume of the urine solution through the orifice the number per unit volume and the size distribution will be counted and reported. The Ramus is an automated microbiology system designed to count and categorise micro-organisms and leucocytes in urine.2324 It will screen urine samples for significant bacteriuria at concentrations of > 105 organisms/ml. Leucocytes are counted separately and reported simultaneously as a hard copy printout. Urine (50 p1) is diluted in 2-5 ml of electrolyte solution in a U-tray designed to analyse a maximum of 32 urine samples. The U-tray is placed into the Ramus analyser unit, information entered via the keyboard, and the analysis automatically continues until all samples have been read.
BIOLUMINESCENCE ASSAY
A total of 2000 urine specimens were processed, randomly selected from those received routinely by the laboratory. The bacterial adenosine triphosphate activity (ATP) for each sample was established, all measurements being carried out in the Amerlite Analyser. This is a semiautomated luminometer developed by Amersham International UK which reads light emission from samples in wells of microtitration plates.25 For each test, 10 p1 of well mixed uncentrifuged urine were transferred to a microtitre well. Any non-bacterial adenosine triphosphate activity present was removed before measurements were performed, using a mixture of Triton X-100 to lyse somatic cells, thus releasing cellular ATP and apyrase (Sigma) to destroy this ATP. Triton-apyrase (10 p1) mixture (0 2%) were added to the urine aliquot, mixed well, and incubated at room temperature for 10 minutes. The bacterial ATP was then extracted using 10 pi trichloroacetic acid (2.5%, pH 7-75) and incubated for two minutes at room temperature. It was then possible to determine the amount of bacterial ATP released. Buffer (200 p1) Tris (hydroxylmethyl) methylamine-ethylenediamineacetic acid were added to each well followed by 10 p1 of luciferin-luciferase monitoring reagent (LKBWallac). The resulting light emission was measured directly from the microtitre tray in the Amerlite Analyser. The value obtained was proportional to the amount of ATP present in the sample. A threshold level of 10 arbitary light units was established as the best cut off limit for 105 colony forming units/ml of bacteria in urine. (table 2) on the system produced 45% of these false positive results. Specimen throughput using the Autotrak is high with minimal specimen preparation time, and about 120 urines can be screened every hour using the apparatus with a result-lead time of about 60 seconds for each urine sample.
The Ramus produced similar results to the Autotrak. Sensitivity was 90% (1.4% false negative rate) and the predictive value of a negative result was 98%. False positive results were again high at 22%.
Results from this evaluation showed that the Ramus counted leucocytes accurately but was less accurate in its ability to detect bacteria.23 Positive leucocyte read- ings were the main problem for the high number of false positive readings. This could be due to leucocyte counts being close to threshold values. Specimen throughput was an average of 45 urines in each hour with minimal sample preparation and a result-lead time ofabout one urine every minute. Due to probable faults in the Ramus software, however, reading difficulties occurred with negative urine readings when the result lead time could be extended for up to three minutes. A hard copy printout of RPT (repeat) was the end result in 46 (4%) of the urines processed, which resulted in a considerable delay in the specimen batch screening time. Orifice blockage did occur on two occasions but was easily cleared using the "deblocking" process of the Ramus. The ATP assay using bioluminescence was achieved in this evaluation using the Amerlite Analyser. 25 Sensitivities of 98% and the predictive value of a negative result of 99% were high. False negative results were only 0-5% and the false positive results of this evaluation were only 15%. Most false positive readings were caused by excessive numbers of red blood cells (table 2) . The removal of all somatic ATP when excessive somatic cells are present seems to be the main problem with this method. Extractions and bioluminescence readings of ATP were all performed in the same well as the microtitre plate, which gave the minimal sample presentation time achievable with this method. A total of 96 urine samples (maximum) gives a result-lead time of about 45 minutes and was easily achieved during this evaluation.
The variables of leucocytes, nitrite, and blood concentrations estimated by chemical analysis of dip sticks to indicate significant bacteriuria proved unacceptable. Poor sensitivity (85%) due to a high false negative rate of 3 5% is outside acceptable limits. The nitrite test is too insensitive as an indicator of significant bacteriuria.'5"6 The predictive value for a positive result was only 32% in this evaluation, caused by the poor specificity of the blood indicator test; but the predictive value for a negative result of 97% is clinically useful. '5 Microscopy, as the results show, does produce a rapid accurate and inexpensive screening procedure with a sensitivity of 94% and a predictive value for a 908 Smith, Hudson, Spencer negative result of 97%. The false positive rate is high but poor quality specimens producing obscure microscopy is a major contributory factor. Specimen throughput is about 30 seconds for each urine sample. Microscopical examination, however, is tiring and subjective in interpretation where about 80% of urine samples are negative.
All evaluations were compared with an overnight aerobic incubation at 37°C and a bacterial count of > 10' organisms/ml, according to the criteria laid down by Kass.5 We felt that this was the only way that all the screening methods could be evaluated in the same way. As a result, low counts or presence of fastidious organisms featured as negative results. Urine screening tests are not reliably sensitive below the 105 threshold levels,27 and this may be an important limitation because some urinary tract infections are associated with relatively low concentrations of bacteriuria. This would indicate that screening tests influenced by pyuria are more sensitive for detecting low amounts of bacteriuria.28 Alternatively, in cases of suspected urinary tract infection a test for leucocytes would result in poor test specificity as these cells are often found in excessive numbers in uninfected patients and may also be absent in patients with urinary tract infection. 29 Microscopy, bioluminescence, acridine-orange staining, and particle counting all showed high sensitivities (87-100%) but variable specificities (68%-79%). Sensitivities from this study did not seem to be affected by the method of screening used (that is, bacteria alone compared with bacteria plus leucocytes). Bioluminescence, however, a direct method evaluated to detect bacteria alone and not bacteria and leucocytes, produced the highest specificity of 79% and the lowest false positive results (15%).
All of the above techniques gave excellent predictive values for a negative result (97%-100%) but only marginal predictive values for a positive result (31 %-61%).
It would therefore be inappropriate to base the decision to begin treatment on the positive results achieved with any of these methods. It would also seem appropriate to use these methods to screen for negative urine samples.
General assessment of laboratory demands show the ever increasing workload to be changing in nature, requiring the screening of more potentially negative specimens.29 Current bacteriological methods are incapable of further economies without real loss of precision and reliability of the results obtained. Rapid techniques which do not depend on culture and are linked to automated apparatus could fulfil the objectives of standardisation, speed, reliability, sensitivity, specificity and the cost effectiveness required of contemporary clinical microbiology.'2 Automation could change the role of clinical microbiology from the present day confirmatory service to a proper diagnostic discipline.'
The initial capital expenditure incurred in automation will inevitably be high (table 3) . Capital and revenue consequences for automation, plus regular maintenance, are all factors to be considered. These costs, however, could be offset in situations where staff recruitment is a problem. The situation for which a fully automated urine screening method could be of use is one in which the specimen quota is high (more than 300 urines every day), staff recruitment is a problem, and the incidence of disease is low. In this situation the infected patient would be correctly identified and many ofthe specimens from the uninfected group would be eliminated from further investigation.3' We believe that the data presented here support the conclusion to advocate screening out, without culture ifpossible, most ofthe urine specimens submitted to the laboratory.
